Home  |  Contact

Cellosaurus TTC-1318 (CVCL_AQ33)

Cell line name TTC-1318
Accession CVCL_AQ33
Resource Identification Initiative To cite this cell line use: TTC-1318 (RRID:CVCL_AQ33)
Disease Embryonal rhabdomyosarcoma (NCIt: C8971)
Embryonal rhabdomyosarcoma (ORDO: Orphanet_99757)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Sex of cell Male
Category Cancer cell line
STR profile Source(s): COG

Markers:
AmelogeninX,Y
CSF1PO10,11
D2S133820,24
D3S135815,17
D5S81811
D7S8209,12
D8S117913,14
D13S31711,12
D16S53912,13
D18S5112,15
D19S43314,15
D21S1132.2
FGA20,24.2
TH019,9.3
TPOX8,9
vWA17,18

Run an STR similarity search on this cell line
Publications

PubMed=19887553; DOI=10.1158/1535-7163.MCT-09-0365
Hu K.-J., Lee C., Qiu D.-X., Fotovati A., Davies A., Abu-Ali S., Wai D.H., Lawlor E.R., Triche T.J., Pallen C.J., Dunn S.E.
Small interfering RNA library screen of human kinases and phosphatases identifies polo-like kinase 1 as a promising new target for the treatment of pediatric rhabdomyosarcomas.
Mol. Cancer Ther. 8:3024-3035(2009)

PubMed=23665679; DOI=10.1038/onc.2013.129
Sokolowski E., Turina C.B., Kikuchi K., Langenau D.M., Keller C.
Proof-of-concept rare cancers in drug development: the case for rhabdomyosarcoma.
Oncogene 33:1877-1889(2014)

Cross-references
Encyclopedic resources Wikidata; Q54973232
Entry history
Entry creation02-May-2016
Last entry update21-Mar-2023
Version number4